§ 826a. Attorney General report on drug shortages
259 words·~1 min read·
/usc/title-21/section-826aA research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 6 months after July 9, 2012, and annually thereafter, the Attorney General shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on the Judiciary of the Senate a report on drug shortages that—
(1)identifies the number of requests received under section 826(h) of this title (as added by section 1005 of this Act), the average review time for such requests, the number of requests granted and denied under such section, and, for each of the requests denied under such section, the basis for such denial;
(2)describes the coordination between the Drug Enforcement Administration and Food and Drug Administration on efforts to prevent or alleviate drug shortages; and
(3)identifies drugs containing a controlled substance subject to section 826 of this title when such a drug is determined by the Secretary to be in shortage.
(Pub. L. 112–144, title X, § 1006, July 9, 2012, 126 Stat. 1105.)
Connections4 cite this · traces to 2
Cited by 4 sections
statute-compilations
4 references not yet in our index
- Pub. L. 112–144, title X, § 1006
- 126 Stat. 1105
- section 1005 of Pub. L. 112–144
- section 1001(b) of Pub. L. 112–144
Citation graph
cites case law
§ 826a
Attorney General report on drug shortages
Fed. Reg.×2
Stat. Comp.×1
Stat.×1
Pub. L.Pub. L. 112–144, title X, § 1006
Stat.126 Stat. 1105
Pub. L.section 1005 of Pub. L. 112–144
Pub. L.section 1001(b) of Pub. L. 112–144
Cites 6Cited by 4 across 3 sources